BioCentury
ARTICLE | Clinical News

AV4025: Phase I started

August 19, 2013 7:00 AM UTC

Alla Chem LLC, Hallandale Beach, Fla. Product: AV4025 Business: Infectious Molecular target: HCV NS5A protein Description: HCV NS5A inhibitor Indication: Treat chronic HCV infection Endpoint: Safet...